Gene · 3093
Papers3,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation. | Cell Death Dis | 2022 | 35145062 | PubTator, text mining | PubMed |
| Antiflammatory activity and potential dermatological applications of characterized humic acids from a lignite and a green compost. | Sci Rep | 2022 | 35140310 | PubTator, text mining | PubMed |
| Mechanisms of motor symptom improvement by long-term Tai Chi training in Parkinson's disease patients. | Transl Neurodegener | 2022 | 35125106 | PubTator, text mining | PubMed |
| Tsg101/ESCRT-I recruitment regulated by the dual binding modes of K63-linked diubiquitin. | Structure | 2022 | 35120596 | PubTator, text mining | PubMed |
| Hypoxic stress disrupts HGF/Met signaling in human trophoblasts: implications for the pathogenesis of preeclampsia. | J Biomed Sci | 2022 | 35114998 | PubTator, text mining | PubMed |
| Screening and identification of novel candidate biomarkers of focal cortical dysplasia type II via bioinformatics analysis. | Childs Nerv Syst | 2022 | 35112146 | PubTator, text mining | PubMed |
| Structural characterization of Linum usitatissimum hydroxynitrile lyase: A new cyanohydrin decomposition mechanism involving a cyano-zinc complex. | J Biol Chem | 2022 | 35101448 | PubTator, text mining | PubMed |
| Advances in Understanding the Role of Aloe Emodin and Targeted Drug Delivery Systems in Cancer. | Oxid Med Cell Longev | 2022 | 35087619 | PubTator, text mining | PubMed |
| Dysregulation of the miR-16-WWP1 signalling pathway leads to colorectal tumorigenesis. | Clin Transl Med | 2022 | 35083873 | PubTator, text mining | PubMed |
| Functional connectome of brainstem nuclei involved in autonomic, limbic, pain and sensory processing in living humans from 7 Tesla resting state fMRI. | Neuroimage | 2022 | 35074504 | PubTator, text mining | PubMed |
| Reveals of quercetin's therapeutic effects on oral lichen planus based on network pharmacology approach and experimental validation. | Sci Rep | 2022 | 35064144 | PubTator, text mining | PubMed |
| The Emerging Role of Non-Coding RNAs in the Regulation of Virus Replication and Resultant Cellular Pathologies. | Int J Mol Sci | 2022 | 35055001 | PubTator, text mining | PubMed |
| Epigenome-Wide DNA Methylation Profiling in Colorectal Cancer and Normal Adjacent Colon Using Infinium Human Methylation 450K. | Diagnostics (Basel) | 2022 | 35054365 | PubTator, text mining | PubMed |
| Cell Cycle Regulation by Heat Shock Transcription Factors. | Cells | 2022 | 35053319 | PubTator, text mining | PubMed |
| circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis. | Mol Cancer | 2022 | 35045883 | PubTator, text mining | PubMed |
Integration of gene co-expression analysis and multi-class SVM specifies the functional players involved in determining the fate of HTLV-1 infection toward the development of cancer (ATLL) or neurological disorder (HAM/TSP). | PLoS One | 2022 | 35041720 | PubTator, text mining | PubMed |
| A Novel Autophagy-Related Prognostic Risk Model and a Nomogram for Survival Prediction of Oral Cancer Patients. | Biomed Res Int | 2022 | 35036428 | PubTator, text mining | PubMed |
| Identification of a ferroptosis-related gene pair biomarker with immune infiltration landscapes in ischemic stroke: a bioinformatics-based comprehensive study. | BMC Genomics | 2022 | 35033021 | PubTator, text mining | PubMed |
| Study on the Mechanism of Compound Kidney-Invigorating Granule for Osteoporosis based on Network Pharmacology and Experimental Verification. | Evid Based Complement Alternat Med | 2022 | 35027934 | PubTator, text mining | PubMed |
| RNA-Seq Explores the Mechanism of Oxygen-Boosted Sonodynamic Therapy Based on All-in-One Nanobubbles to Enhance Ferroptosis for the Treatment of HCC. | Int J Nanomedicine | 2022 | 35027829 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3093/papers?page=42